Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:742-746
Published online before print February 7, 2005, doi: 10.1161/01.HYP.0000154785.50570.63
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/4/742    most recent
01.HYP.0000154785.50570.63v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dechend, R.
Right arrow Articles by Müller, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dechend, R.
Right arrow Articles by Müller, D. N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Risk Pregnancy
Related Collections
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Other Vascular biology

(Hypertension. 2005;45:742.)
© 2005 American Heart Association, Inc.


Original Articles

Agonistic Autoantibodies to the AT1 Receptor in a Transgenic Rat Model of Preeclampsia

Ralf Dechend; Petra Gratze; Gerd Wallukat; Erdenechimeg Shagdarsuren; Ralf Plehm; Jan-Hinrich Bräsen; Anette Fiebeler; Wolfgang Schneider; Silvia Caluwaerts; Lisbeth Vercruysse; Robert Pijnenborg; Friedrich C. Luft; Dominik N. Müller

From Medical Faculty of the Charité (R.D., P.G., E.S., R.P., H.-H.B., A.F., W.S., F.C.L.), Franz Volhard Clinic and Department of Pathology, HELIOS-Klinikum Berlin, Germany; Max Delbrück Center for Molecular Medicine (G.W., D.N.M.), Berlin, Germany; and Experimenteel Laboratorium Gynecologie (S.C., L.V., R.P.), Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium.

Correspondence to Friedrich C. Luft, Franz Volhard Clinic, Wiltberg Strassse 50, 13125 Berlin, Germany. E-mail luft{at}fvk-berlin.de

We used rats transgenic for the human angiotensinogen (hAogen) gene and the human renin (hRen) gene and crossed the strains to produce a model of preeclampsia in the dams. The female (n=9) hAogen x male hRen cross had severe (telemetry-measured) hypertension and albuminuria, which developed during the last trimester of pregnancy and subsided after delivery. The converse cross (n=9) and control (n=9) SD rats did not. We demonstrated that the female hAogen x male hRen cross had agonistic antibodies capable of activating the angiotensin (Ang) II AT1 receptor (AT1R-AA) and defined the epitope on the receptor’s second extracellular loop. The phenomenon also occurs in humans with preeclampsia. The rats displayed renal histology reminiscent of preeclampsia, including fibrin deposition confined to the glomeruli. The complement system was activated in glomeruli and IgG deposits were present that may represent AT1R-AA. Finally, we observed an atherosis-like lesion in the spiral arteries of the placental bed, which we called placental-bed arteriolosclerosis. Our model may be relevant to preeclampsia in humans.


Key Words: preeclampsia • rats, transgenic • antibodies • immune systems • renin-angiotensin system




This article has been cited by other articles:


Home page
HypertensionHome page
B. LaMarca, M. Parrish, L. F. Ray, S. R. Murphy, L. Roberts, P. Glover, G. Wallukat, K. Wenzel, K. Cockrell, J. N. Martin Jr, et al.
Hypertension in Response to Autoantibodies to the Angiotensin II Type I Receptor (AT1-AA) in Pregnant Rats: Role of Endothelin-1
Hypertension, October 1, 2009; 54(4): 905 - 909.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Verlohren, D. N. Muller, F. C. Luft, and R. Dechend
Immunology in Hypertension, Preeclampsia, and Target-Organ Damage
Hypertension, September 1, 2009; 54(3): 439 - 443.
[Full Text] [PDF]


Home page
HypertensionHome page
F. Herse, S. Verlohren, K. Wenzel, J. Pape, D. N. Muller, S. Modrow, G. Wallukat, F. C. Luft, C. W.G. Redman, and R. Dechend
Prevalence of Agonistic Autoantibodies Against the Angiotensin II Type 1 Receptor and Soluble fms-Like Tyrosine Kinase 1 in a Gestational Age-Matched Case Study
Hypertension, February 1, 2009; 53(2): 393 - 398.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. LaMarca, G. Wallukat, M. Llinas, F. Herse, R. Dechend, and J. P. Granger
Autoantibodies to the Angiotensin Type I Receptor in Response to Placental Ischemia and Tumor Necrosis Factor {alpha} in Pregnant Rats
Hypertension, December 1, 2008; 52(6): 1168 - 1172.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. D. LaMarca, J. Gilbert, and J. P. Granger
Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia
Hypertension, April 1, 2008; 51(4): 982 - 988.
[Full Text] [PDF]


Home page
HypertensionHome page
S. Verlohren, M. Niehoff, L. Hering, N. Geusens, F. Herse, A. N. Tintu, A. Plagemann, F. LeNoble, R. Pijnenborg, D. N. Muller, et al.
Uterine Vascular Function in a Transgenic Preeclampsia Rat Model
Hypertension, February 1, 2008; 51(2): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Xia, S. M. Ramin, and R. E. Kellems
Potential Roles of Angiotensin Receptor-Activating Autoantibody in the Pathophysiology of Preeclampsia
Hypertension, August 1, 2007; 50(2): 269 - 275.
[Full Text] [PDF]


Home page
HypertensionHome page
C. A. Hubel, G. Wallukat, M. Wolf, F. Herse, A. Rajakumar, J. M. Roberts, N. Markovic, R. Thadhani, F. C. Luft, and R. Dechend
Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia
Hypertension, March 1, 2007; 49(3): 612 - 617.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
D Micheloud, L Nuno, M Rodriguez-Mahou, S Sanchez-Ramon, M C Ortega, A Aguaron, E Junco, J Carbone, E Fernandez-Cruz, L Carreno, et al.
Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy
Lupus, December 1, 2006; 15(12): 881 - 885.
[Abstract] [PDF]


Home page
HypertensionHome page
T. Walther, G. Wallukat, A. Jank, S. Bartel, H.-P. Schultheiss, R. Faber, and H. Stepan
Angiotensin II Type 1 Receptor Agonistic Antibodies Reflect Fundamental Alterations in the Uteroplacental Vasculature
Hypertension, December 1, 2005; 46(6): 1275 - 1279.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Lam, K.-H. Lim, and S. A. Karumanchi
Circulating Angiogenic Factors in the Pathogenesis and Prediction of Preeclampsia
Hypertension, November 1, 2005; 46(5): 1077 - 1085.
[Abstract] [Full Text] [PDF]